BYVASDA is an anti-vascular endothelial growth factor (VEGF) humanized monoclonal antibody and a bevacizumab biosimilar independently developed by Innovent Biologics... Dec 28
ASC42 received Fast Track designation from the US FDA for NASH... Dec 28
The positive assessment from ANVISA reaffirms WuXi Biologics' strong commitment to offering partners a global manufacturing network of the highest standard... Dec 28
-Advertisements-